Rebastinib Terminated Phase 1 Trials for Recurrent Breast Carcinoma / Breast Adenocarcinoma / Breast Cancer / Carcinoma Breast Stage IV / Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Treatment